<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Public Health">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Public Health</JournalTitle>
      <Issn>2251-6085</Issn>
      <Volume>54</Volume>
      <Issue>7</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>07</Month>
        <Day>08</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Synbiotic-Containing Bacillus coagulans (GBI-30) and the Effects on Glycemic Control, Androgen Hormones and Anthropometric Indices in Women with Polycystic Ovarian Syndrome</title>
    <FirstPage>1540</FirstPage>
    <LastPage>1550</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Hariri</LastName>
        <affiliation locale="en_US">Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Zahra</FirstName>
        <LastName>Yari</LastName>
        <affiliation locale="en_US">Department of Nutrition Research, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Nilghaz</LastName>
        <affiliation locale="en_US">Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Monirsadat</FirstName>
        <LastName>Mirhoseini</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, Faculty of Nutrition and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Sedighe</FirstName>
        <LastName>Hoseini</LastName>
        <affiliation locale="en_US">Department of Obstetrics and Gynecology, Preventative Gynecology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Khadijeh</FirstName>
        <LastName>Abhari</LastName>
        <affiliation locale="en_US">Department of Food Science and Technology, National Nutrition and Food Technology Research Institute, Faculty of Nutri-tion Sciences and Food Technology, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Golbon</FirstName>
        <LastName>Sohrab</LastName>
        <affiliation locale="en_US">Department of Clinical Nutrition and Dietetics, Faculty of Nutrition Sciences and Food Technology, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2023</Year>
        <Month>08</Month>
        <Day>27</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>11</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Background: We aimed to investigate the effect of synbiotic supplement-containing spore-forming Bacillus coagulans (GBI-30) on the glycemic, hormonal and anthropometric parameters in patients with PCOS.
Methods: In this randomized, triple-blind, placebo-controlled trial, 72 patients with PCOS were randomly and equally assigned to receive a daily sachet of synbiotic (containing Bacillus coagulans (GBI-30), Lactobacillus rhamnosus, Lactobacillus helveticus, and fructooligosaccharide (FOS)) or placebo for 12 wk. Glycemic, hormonal and anthropometric parameters were measured at baseline and after the 12-week of intervention.
Results: At the end, 60 patients completed the study. After adjustment for potential confounders, significant decrease in insulin (&#x2212;3.38&#xB1;20.20 vs. +2.33, P=0.042), homeostatic model assessment for insulin resistance (HOMA-IR) (&#x2212;0.43&#xB1;3.61 vs. +0.73 &#xB1; 2.91, P=0.044) and dehydroepiandrosterone sulfate (DHEAS) (&#x2212;1.47&#xB1;6.62 vs. + 0.03 &#xB1; 2.06, P=0.047) was observed in the intervention group compared to the control group. Supplementation with synbiotic failed to show a significant effect on anthropometric parameters and fasting blood sugar.
Conclusion: Overall, 12 wk supplementation with synbiotic-containing Bacillus coagulans (GBI-30) can offer additional benefit to lifestyle intervention on metabolic status of women with polycystic ovarian syndrome.</abstract>
    <web_url>https://ijph.tums.ac.ir/index.php/ijph/article/view/33025</web_url>
    <pdf_url>https://ijph.tums.ac.ir/index.php/ijph/article/download/33025/8608</pdf_url>
  </Article>
</Articles>
